Endocyte completes secondary public offering
The West Lafayette-based biotech firm raised about $66.8 million by selling nearly 6.7 million shares of company stock, priced at $12.26 per share.
Health Care & Life Sciences
Articles
Indiana asks court to lift Planned Parenthood order
Indiana asked a federal appeals court Monday to lift a judge's order blocking parts of a new abortion law that cuts some public Planned Parenthood funding, saying the issue should be decided by Medicaid officials and not the courts.
Consumers grow allergic to health care costs
Deloitte found that 20 percent of consumers have cut back on health care spending and 75 percent say the economic slowdown has had some impact on their willingness to spend on health care.
WellPoint fails to profit on consumer pullback
With recession-weary Americans going to the doctor less, health insurer WellPoint Inc. should be enjoying higher profits. But it isn’t working out that way.
Lilly wins appeals court ruling in Strattera patent case
The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., overturned Friday a judge’s decision that Lilly’s patent on attention-deficit treatment Strattera was invalid.
Timmy Foundation changes name to reflect global reach
The organization that organizes medical teams to serve overseas is now called Timmy Global Health.
Eli Lilly’s Elanco unit blossoming at just the right time
An investment firm projects that the Elanco animal-health business will generate sales of nearly $2 billion by 2012 and surpass $3 billion by 2018.
Experts tell state panel marijuana prohibition has failed
A state panel heard from a parade of experts Thursday as it began studying whether to legalize marijuana in Indiana or reduce criminal penalties on small amounts of the drug.
St. Vincent plans 200 jobs for Fishers expansion
The hospital system said it will expand its Medical Center Northeast facility to a 40-bed inpatient hospital. Construction is set to begin in September and should be completed by December 2012.
Health care use trend may temper premium hikes
Consumers may catch a little break when their health insurance policies renew. Lower-than-expected use of health care has helped push insurer earnings higher and that may temper how much they increase premiums.
Indiana life sciences leaders look toward the future
Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue’s Discovery Park.
WellPoint profit falls but exceeds Wall Street expectations
Indianapolis-based WellPoint earned $702 million in the latest quarter after earning $722 million a year ago. It also raised its full-year profit forecast.
Attention race fans: Hot dogs may be hazardous to your health
A billboard near the Indianapolis Motor Speedway features an image of hot dogs poking out of a cigarette pack adorned with a skull and crossbones. A message warns viewers that "hot dogs can wreck your health."
Obesity, tobacco use among targets of state’s health priorities
Indiana health officials are targeting infant mortality, obesity, tobacco use and other health priorities in a new five-year plan aimed at improving the health of Hoosiers.
Despite sales spike, Effient has middling prospects
Remember Effient? The blood thinner that was once Eli Lilly and Co.’s greatest post-Zyprexa hope and then, after a slow launch, was dismissed as an abject failure? Well, it’s turning out to defy both predictions.
WellPoint insures two-thirds of Hoosier workers
Indianapolis-based WellPoint claimed 63 percent of all employees covered by small-group employers and 66 percent of the workers at large-group employers, according to Seattle-based actuarial firm Milliman Inc.
IU Health name change means business for tech firms
Clarian Health’s recent rebranding to Indiana University Health has been good business for at least three companies in Indianapolis’ so-called measured-marketing sector. Such firms help a company overhaul its website and make changes to the “tweetosphere” and other social media channels.
Lilly stock rises after drugmaker reports higher sales
Investors responded favorably Thursday to Eli Lilly and Co.’s surprisingly strong second-quarter revenue, even though its profit fell due to rapid spending on marketing and research.
Pfizer won’t break up animal unit for potential Lilly bid
Pfizer Inc., the world’s biggest drugmaker, said it isn’t interested in breaking up its animal health unit after Indianapolis-based Eli Lilly and Co. expressed interest in buying some of its products.
UPDATE: Medco acquisition could lead to local consolidation
It’s not yet clear how Express Scripts Inc.’s $29.1 billion acquisition of rival Medco Health Solutions will affect the companies’ central Indiana operations—or their 800-plus employees at two facilities here.